Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ascletis

- PMLiVE

Sagimet announces positive results for Ascletis’ denifanstat in moderate to severe acne

Over 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment

- PMLiVE

Chinese biotechs aim PD-L1 antibody at hepatitis B

Cancer therapies could help boost patient's immune system

- PMLiVE

Dermira craters as acne drug fails late-stage test

The US biotech lost two-thirds of its share value after the news broke

- PMLiVE

France ignores EMA and suspends Bayer’s Diane 35

National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict

- PMLiVE

EMA says Bayer’s Diane 35 should remain on European market

Agency investigation concludes acne treatment's benefits outweigh its risks

- PMLiVE

Roche taps local expertise for hep C drug in China

Partners with Chinese-American biotech company Ascletis

- PMLiVE

Bayer’s Diane 35 faces ban in France

Follows investigation into blood clot-related deaths

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links